Trump win boosts drug stocks as prospect of price curbs recedes
Pharmaceutical stocks leapt on Wednesday as Republican Donald Trump's U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded. News that a Californian proposal aimed at reining in rising prices for prescription drugs was headed for defeat in a state ballot also buoyed the mood. Trump&039;s victory over Hillary Clinton, whose drug pricing criticisms have weighed on shares for more than a year, is not without risk, however.
